Harel Insurance Investments & Financial Services’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$181K Sell
500
-200
-29% -$68.5K ﹤0.01% 345
2026
Q1
$246K Buy
700
+200
+40% +$71.3K ﹤0.01% 281
2025
Q4
$164K Buy
+500
New +$159K ﹤0.01% 288
2024
Q4
Sell
-1,202
Closed -$387K 468
2024
Q3
$387K Buy
1,202
+106
+10% +$34.7K 0.01% 179
2024
Q2
$342K Buy
1,096
+77
+8% +$22.6K 0.01% 202
2024
Q1
$290K Sell
1,019
-239
-19% -$69.9K 0.01% 213
2023
Q4
$363K Buy
1,258
+36
+3% +$9.81K 0.01% 232
2023
Q3
$328K Buy
+1,222
New +$305K 0.01% 230
2023
Q2
Sell
-692
Closed -$167K 688
2023
Q1
$167K Buy
692
+199
+40% +$48.8K ﹤0.01% 352
2022
Q4
$129K Sell
493
-85
-15% -$22.8K ﹤0.01% 332
2022
Q3
$132K Buy
578
+298
+106% +$72.2K ﹤0.01% 346
2022
Q2
$68K Buy
+280
New +$68.6K ﹤0.01% 463
2022
Q1
Sell
-5,300
Closed -$1.2M 699
2021
Q4
$1.2M Sell
5,300
-3,026
-36% -$639K 0.02% 163
2021
Q3
$1.77M Buy
8,326
+6,870
+472% +$1.58M 0.05% 101
2021
Q2
$1.16M Buy
1,456
+283
+24% +$69.6K 0.03% 290
2021
Q1
$975K Sell
1,173
-4,000
-77% -$954K 0.02% 363
2020
Q4
$3.83M Sell
5,173
-3,109
-38% -$717K 0.09% 104
2020
Q3
$2.1M Buy
8,282
+6,222
+302% +$1.54M 0.07% 76
2020
Q2
$486K Buy
2,060
+225
+12% +$51.3K 0.02% 131
2020
Q1
$372K Buy
1,835
+793
+76% +$173K 0.02% 118
2019
Q4
$251K Buy
1,042
+930
+830% +$205K 0.01% 181
2019
Q3
$22K Sell
112
-88
-44% -$16.9K ﹤0.01% 379
2019
Q2
$37K Hold
200
﹤0.01% 341
2019
Q1
$38K Sell
200
-300
-60% -$57.3K ﹤0.01% 290
2018
Q4
$97K Buy
500
+300
+150% +$58.5K 0.01% 236
2018
Q3
$41K Sell
200
-800
-80% -$158K ﹤0.01% 356
2018
Q2
$185K Buy
1,000
+130
+15% +$23K 0.01% 191
2018
Q1
$148K Sell
870
-38
-4% -$6.97K 0.01% 242
2017
Q4
$158K Sell
908
-641
-41% -$113K 0.01% 231
2017
Q3
$289K Sell
1,549
-400
-21% -$70.9K 0.02% 143
2017
Q2
$336K Sell
1,949
-101
-5% -$16.4K 0.03% 135
2017
Q1
$332K Buy
2,050
+2,022
+7,221% +$336K 0.03% 122
2016
Q4
$4K Hold
28
﹤0.01% 340
2016
Q3
$5K Sell
28
-2,293
-99% -$388K ﹤0.01% 420
2016
Q2
$353K Buy
2,321
+2,293
+8,189% +$356K 0.04% 107
2016
Q1
$4K Buy
+28
New +$4.16K ﹤0.01% 421

Other funds holding AMGN

Harel Insurance Investments & Financial Services's AMGN Position: Q2 2026 in Review

Harel Insurance Investments & Financial Services reduced its Amgen (AMGN) stake by 29% in Q2 2026, selling an estimated $68.5K and leaving 500 shares worth $181K. The position accounts for ﹤0.01% of the portfolio, ranked #345.

Harel Insurance Investments & Financial Services first reported a position in AMGN in Q1 2016 and has held it in 36 quarters since. The position peaked at $3.83M in Q4 2020. 1,684 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Harel Insurance Investments & Financial Services held 500 shares of Amgen worth $181K as of Q2 2026.
  • Harel Insurance Investments & Financial Services sold 200 Amgen shares in Q2 2026, an estimated $68.5K.
  • Amgen made up ﹤0.01% of Harel Insurance Investments & Financial Services's portfolio in Q2 2026, its #345 holding.
  • Harel Insurance Investments & Financial Services first reported a position in Amgen in Q1 2016 and has held it in 36 quarters since.
  • Harel Insurance Investments & Financial Services's Amgen position peaked at $3.83M in Q4 2020.
  • 1,684 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Harel Insurance Investments & Financial Services's 13F filing for Q2 2026, filed 29 Jul 2026.